Xbit alert - levi & korsinsky has commenced an investigation on behalf of xbiotech inc. shareholders who lost money

New york, ny / accesswire / december 26, 2024 / levi & korsinsky notifies investors that it has commenced an investigation of xbiotech inc. ("xbiotech inc.") (nasdaq:xbit) concerning possible violations of federal securities laws. xbiotech announced on december 23, 2024, that it was pausing a phase 2 rheumatoid arthritis program after the candidate, natrunix, failed to meet its primary endpoint.
XBIT Ratings Summary
XBIT Quant Ranking